The WACC of Mouwasat Medical Services Company SJSC (4002.SR) is 13.1%.
| Range | Selected | |
| Cost of equity | 11.80% - 15.20% | 13.50% |
| Tax rate | 3.90% - 4.60% | 4.25% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 11.5% - 14.7% | 13.1% |
| Category | Low | High |
| Long-term bond rate | 5.9% | 6.4% |
| Equity market risk premium | 6.1% | 7.1% |
| Adjusted beta | 0.97 | 1.16 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 11.80% | 15.20% |
| Tax rate | 3.90% | 4.60% |
| Debt/Equity ratio | 0.05 | 0.05 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 11.5% | 14.7% |
| Selected WACC | 13.1% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 4002.SR:
cost_of_equity (13.50%) = risk_free_rate (6.15%) + equity_risk_premium (6.60%) * adjusted_beta (0.97) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.